Advertisement
Screener

ORGENESIS INC. Accounts Receivable, Credit Loss Expense (Reversal)

ORGENESIS INC. Accounts Receivable, Credit Loss Expense (Reversal)

ORGENESIS INC. reported Accounts Receivable, Credit Loss Expense (Reversal) of $2.72 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-26.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ProvisionForDoubtfulAccounts · last filed 2026-03-26

  • ORGENESIS INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2024-12-31 was -$1.00K.
  • ORGENESIS INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2024-09-30 was $0.00.
  • ORGENESIS INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2024-06-30 was -$500.00K, a 103.36% decline year-over-year.
  • ORGENESIS INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2024-03-31 was $3.23M, a 66.01% decline year-over-year.
  • ORGENESIS INC. accounts receivable, credit loss expense (reversal) for fiscal 2024 was $2.72M, a 88.82% decline from fiscal 2023.
  • ORGENESIS INC. accounts receivable, credit loss expense (reversal) for fiscal 2023 was $24.37M.
  • ORGENESIS INC. accounts receivable, credit loss expense (reversal) for fiscal 2017 was $897.00K.
Period endAccounts Receivable, Credit Loss Expense (Reversal) 3 monthAccounts Receivable, Credit Loss Expense (Reversal) 6 monthAccounts Receivable, Credit Loss Expense (Reversal) 6 month as first filedAccounts Receivable, Credit Loss Expense (Reversal) 9 monthAccounts Receivable, Credit Loss Expense (Reversal) 9 month as first filedAccounts Receivable, Credit Loss Expense (Reversal) 12 month
2024-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
-$1.00K
derived: sum of 2 quarters · filed 2026-03-26
-$501.00K
derived: sum of 3 quarters · filed 2026-03-26
$2.72M
10-K · filed 2026-03-26
2024-09-30$0.00
10-Q · filed 2024-11-13
-$500.00K
derived: sum of 2 quarters · filed 2024-11-13
$2.73M
10-Q · filed 2024-11-13
$2.73M
derived: sum of 4 quarters · filed 2026-03-26
2024-06-30-$500.00K
10-Q · filed 2024-08-08
$2.73M
10-Q · filed 2024-08-08
$2.73M
derived: sum of 3 quarters · filed 2026-03-26
$2.73M
derived: sum of 4 quarters · filed 2026-03-26
2024-03-31$3.23M
10-Q · filed 2024-05-20
$3.23M
derived: sum of 2 quarters · filed 2026-03-26
$3.23M
derived: sum of 3 quarters · filed 2026-03-26
$18.10M
derived: sum of 4 quarters · filed 2026-03-26
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$0.00
derived: sum of 2 quarters · filed 2026-03-26
$14.88M
derived: sum of 3 quarters · filed 2026-03-26
$24.37M
10-K · filed 2026-03-26
2023-09-30$0.00
10-Q · filed 2024-11-13
$14.88M
derived: sum of 2 quarters · filed 2024-11-13
$24.37M
10-Q · filed 2024-11-13
$2.69M
10-Q/A · filed 2024-04-15
2023-06-30$14.88M
10-Q · filed 2024-08-08
$24.37M
10-Q · filed 2024-08-08
$2.69M
10-Q/A · filed 2024-04-15
2023-03-31$9.49M
10-Q · filed 2024-05-20
2017-11-30$897.00K
10-K · filed 2019-02-13